...
首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >'CIN' no more: The use of contrast volume to e-GFR ratio to predict and prevent contrast-induced acute kidney injury
【24h】

'CIN' no more: The use of contrast volume to e-GFR ratio to predict and prevent contrast-induced acute kidney injury

机译:不再“ CIN”:使用造影剂体积与e-GFR的比率预测和预防造影剂引起的急性肾损伤

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We read with interest the study from Mager et al., which examined the relationship between contrast volume to estimated glomerular filtration rate (eGFR) ratio, and clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) who had undergone primary percutaneous coronary intervention (PCI). Contrast-induced acute kidney injury or contrast-induced nephropathy (CIN) is an important and not rare complication in patients undergoing PCI or diagnostic modalities involving contrast media. This complication has become a significant source of hospital morbidity and mortality with the ever-increasing use of contrast media in diagnostic and therapeutic procedures. With no specific treatment for CIN, identification and stratification of patient risk and preventative measures are paramount.
机译:我们感兴趣地阅读了Mager等人的研究,该研究检查了接受原发性经皮冠状动脉介入治疗的ST抬高型心肌梗死(STEMI)患者的造影剂体积与估计的肾小球滤过率(eGFR)之比与临床结局之间的关系。 (PCI)。在接受PCI或涉及造影剂的诊断方式的患者中,造影剂引起的急性肾损伤或造影剂引起的肾病(CIN)是重要且并非罕见的并发症。随着在诊断和治疗过程中造影剂的不断使用,这种并发症已成为医院发病率和死亡率的重要来源。由于没有针对CIN的特殊治疗方法,对患者风险的识别和分层以及预防措施至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号